1. Sakai K, Iwatsuki M, Kaneta T, Kimishima A, Asami Y, Sunazuka T, Masuma R, Nonaka K. Sesquicillin F, a new insecticidal meroterpenoid produced by Mariannaea macrochlamydospora FKI-4735. J. Antibiot., 2021, 74, 817-820, doi: 10.1038/s41429-021-00456-9
2. Saito R, Sennari G, Nakajima A, Kimishima A, Iwatsuki M, Ishiyama A, Hokari R, Hirose T, Sunazuka T. Discoveries and Syntheses of Highly Potent Antimalarial Troponoids. Chem. Pharm. Bull., 2021, 16, 2016-2111, doi: 10.1248/cpb.c21-00132
3. Sakai K, Unten Y, Kimishima A, Nonaka K, Chinen T, Sakai K, Usui T, Shiomi K, Iwatsuki M, Murai M, Miyoshi H, Asami Y, Omura S. Traminines A and B, produced by Fusarium concentricum, inhibit oxidative phosphorylation in Saccharomyces cerevisiae mitochondria. J. Ind. Microbiol. Biotechnol., 2021, in press, doi.org/10.1093/jimb/kuab051
4. Koike R, Watanabe Y, Kato K, Mikasa Y, Shimizu K, Nonaka K, Honsho M, Suga T, Hokari R, Ishiyama A, Asami Y, Iwatsuki M. Shikinefragalides A-D, new tricyclic macrolides produced by Stachybotryaceae sp. FKI-9632. J. Antibiot., 2022, 75, 199-206. doi: 10.1038/s41429-022-00512-y
5. Kobayashi C, Watanabe Y, Oshima M, Hirose T, Yamasaki M, Iwamoto M, Iwatsuki M, Asami Y, Kuramochi K, Wakae K, Aizaki H, Muramatsu M, Sureau C, Sunazuka T, Watashi K. Fungal secondary metabolite exophillic acid selectively inhibits the entry of Hepatitis B and D viruses. Viruses, 2022, 14, 764. doi: 10.3390/v14040764
6. Kondo N, Sakai K, Kimishima A, Hokari R, Honsho M, Sato M, Naher K, Yuge H, Iwatsuki M, Nonaka K, Asami Y. Confluenine G, a new compound from a basidiomycetous yeast Moesziomyces sp. FKI-9540 derived the gut of a moth Acherontia lachesis (Lepidoptera, Sphingidae). Biosci. Biotechnol. Biochem., 2022, in press doi: 10.1093/bbb/zbac062
7. Yonezawa H, Ikeda A, Takahashi R, Endo H, Sugawara Y, Goto M, Kanno M, Ogawa S, Nakamura K, Ujiie H, Iwatsuki M, Hirose T, Sunazuka T, Uehara Y, Nishiya N. Ivermectin represses Wnt/β-catenin signaling by binding to TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases. iScience, 2022, 25, 103912. doi: 10.1016/j.isci.2022.103912
8. Kimishima A, Hagimoto D, Honsho M, Watanabe Y, Iwatsuki M, Tsutsumi H, Inahashi Y, Naher K, Sakai K, Kuwae A, Abe A, Asami Y. Insights into the structure-activity relationship of a type III secretion system inhibitor, aurodox. Bioorg. Med. Chem. Lett., 2022, 69, 128779. doi: 10.1016/j.bmcl.2022.128779